3rd International Pharmaceutical Conference and Expo welcome you as our guest to Rome, Italy during April 18-19, 2022. i-Pharma 2022 includes nearly every permutation of knowledge, innovation, technology, and networking; and has the objective of creating an international forum for academicians, practitioners, and business professionals to discuss the soundest issues related to Pharma, Biotech, and Health Care.
This program provides two days of robust discussions in the field of Drug Discovery and Development, Pharmacovigilance and Drug Safety, Novel Drug Delivery Systems and Drug therapy, Pharmaceutical Nanotechnology, Drug Regulatory Affairs, Pharmacology, Neuropharmacology, Nutraceuticals, Pharma Marketing, Orphan and Rare Disease and more.
i-Pharma 2022 offers unparalleled business, research opportunities, and access to new markets in Pharma and Health Care industry. Be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest.
Join us and witness the booming industry by participating at iPharma 2020 and give your career and business access to new opportunities from throughout the world.
The pharmaceutical industry plays a significant role in discovering, developing, producing and marketing drugs for use as medications to reduce the incidence of diseases and enhance the quality of life of people. The increasing demand for innovative drugs has thus triggered a significant rise in R&D investments in the pharmaceutical industry. The global market is expected to grow at an annual rate of 4.9% to $1.3 trillion by 2020. The United States has one of the most supportive environments for the development and commercialization of pharmaceuticals with minimal market barriers. Its strengths include an intellectual property system that encourages innovation through data protection and patent and, a science-based regulatory system, the largest scientific research base endorsed by academic institutions and decades of government research funding, and vigorous capital markets.
The US pharmaceutical market consists of majorly two types of drugs, i.e. traditional drugs and specialty drugs. Specialty drugs are meant for chronic and rare diseases and have gained a strong foothold in recent times. The specialty market has changed over the years with a lot of these drugs being in their final phase of development and is likely to have staggering growth due to factors like an aging population, improving life expectancy and a rise in net per capita. The factors that affect the pharmaceutical market size include disease prevalence, drug affordability, government policies, and some supply-side factors. Biotech drugs include a wide range of products such as therapeutic proteins, vaccines, blood and blood components, tissues, etc. are revolutionizing the treatment of autoimmune disorders and cancer, and are critical to the future of the industry. Drugs are subjected to a variety of laws and regulations that govern the patenting, safety, testing, and efficacy of drugs. With the sequencing of the human genome, clinical research in potential new drug therapies is likely to increase further. Sound drug regulatory regulations provide the foundation for the ethos of drug safety, and for public conviction in medicines.
Janssen R&D (For iPharma 2019) USA
Merck & Co. Inc USA
Ian James Martins Australia
Seoul National University Hospital Korea
Universidade Federal de São Paulo Brazil
Southern Illinois University Edwardsville Illinois
Medipol University Turkey
Labaton Sucharow USA
Cap Solutions USA
State University of New York Downstate Medical Center USA